Medicine company Eli Lilly and Company (NYSE: LLY) announced on Monday that it will pay a fourth-quarter 2024 dividend of USD1.30 per share on its common stock.

This dividend is payable on 10 December 2024 to shareholders of record as of 15 November 2024.

With nearly 150 years in pharmaceutical innovation, Lilly continues to address major global health challenges, including diabetes, obesity, Alzheimer's, immune disorders and hard-to-treat cancers.

Through biotechnology and genetic medicine, Lilly's mission is to improve health outcomes worldwide, focusing on inclusive clinical trials and accessible treatments.